Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Five Minutes with Matthew Walls of EpiStem

This article was originally published in Clinica

Executive Summary

Matthew Walls joined biotechnology firm Epistem as CEO in February 2007. The Manchester, UK-based firm focuses on stem cell technologies for use in therapeutic and biomarker applications. Before joining EpiStem, Mr Walls headed data management firm Oxford BioSignals, and has also worked for chemical company ICI and pharmaceutical giant AstraZeneca

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT086937

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel